副标题: The Beginnings of Biotech
出版年: 2013-4
页数: 232
定价: $ 18.08
ISBN: 9780226045511
内容简介 · · · · · ·
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest g...
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. "Genentech" tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
作者简介 · · · · · ·
萨莉·史密斯·休斯供职于加州伯克利大学班克罗夫特图书馆,是科学历史方面的专家,著有《病毒的历史》(The Virus: A History of the Concept)。此外,她还创作了一系列广泛深入的口述历史,内容涉及生物科学、生物医药学和生物技术领域。
Genentech的书评 · · · · · · ( 全部 8 条 )
科学和商业的平衡,biotech的绝佳范式
读书笔记 | 基因泰克 | 敢于浮于海面的鲸鱼
时势造英雄,英雄本龙凤
这篇书评可能有关键情节透露
成功的生工不多,Genentech虽然已经不是1978x 成立时的样子,但也算差强人意。故事其实多少有些老套与爽文思路,几乎每个做研究的多少都遇到过一些: 1. 两个科学家(Boyer & Cohen)在会议上相见恨晚,高效地提出并施行合作; 2. 文章发表后,有眼光没什么选择的VC代表来找... (展开)跨越达尔文之海死亡之谷的幸存者
这篇书评可能有关键情节透露
“达尔文之海”用来指科学研究到实际产品的转化鸿沟,‘死亡之谷’通常指PoC 到可上市产品的鸿沟。太多太多高校实验室的研究都在海里淹死了,在谷里陷死了,能够跨过达尔之海,穿越死亡之谷的幸存者能够获得基础研究带来的颠覆式创新的最大红利。Genentech 就是典型的代表。 Ge... (展开)坚定的合理的目标加上足够的努力大概会有不错的结果
这篇书评可能有关键情节透露
基因泰克公司的两个创始人,斯万森和伯耶,在性格与能力上有相当强的互补性。斯万森懂得商业,伯耶则拥有技术,懂得科学。基因泰克公司的管理实际上也是在商业和科学之间取得的平衡,科研人员可以发表文章。为了招募足够多的优秀科学家,必须提供吸引科学家的条件,金钱是一方... (展开)> 更多书评 8篇
论坛 · · · · · ·
在这本书的论坛里发言这本书的其他版本 · · · · · · ( 全部3 )
-
中国人民大学出版社 (2017)7.7分 207人读过
-
University of Chicago Press (2011)8.7分 46人读过
以下书单推荐 · · · · · · ( 全部 )
- 科学史 科学哲学 科学文化 科学技术 (NADPH)
谁读这本书? · · · · · ·
二手市场
· · · · · ·
- 在豆瓣转让 有1人想读,手里有一本闲着?
订阅关于Genentech的评论:
feed: rss 2.0
还没人写过短评呢
还没人写过短评呢